These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 38232989)
1. From treatable traits to GETomics in airway disease: moving towards clinical practice. Papi A; Faner R; Pavord I; Baraldi F; McDonald VM; Thomas M; Miravitlles M; Roche N; Agustí A Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38232989 [TBL] [Abstract][Full Text] [Related]
2. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society. Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455 [TBL] [Abstract][Full Text] [Related]
3. Treatable Traits in COPD - A Proposed Approach. Cardoso J; Ferreira AJ; Guimarães M; Oliveira AS; Simão P; Sucena M Int J Chron Obstruct Pulmon Dis; 2021; 16():3167-3182. PubMed ID: 34824530 [TBL] [Abstract][Full Text] [Related]
4. Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report. McDonald VM; Fingleton J; Agusti A; Hiles SA; Clark VL; Holland AE; Marks GB; Bardin PP; Beasley R; Pavord ID; Wark PAB; Gibson PG; ; Eur Respir J; 2019 May; 53(5):. PubMed ID: 30846468 [TBL] [Abstract][Full Text] [Related]
5. Precision medicine and treatable traits in chronic airway diseases - where do we stand? Ulrik CS; Vijverberg S; Hanania NA; Diamant Z Curr Opin Pulm Med; 2020 Jan; 26(1):33-39. PubMed ID: 31644440 [TBL] [Abstract][Full Text] [Related]
6. Treatable traits in pre-COPD: Time to extend the treatable traits paradigm beyond established disease. Dharmage SC; Faner R; Agustí A Respirology; 2024 Jul; 29(7):551-562. PubMed ID: 38862131 [TBL] [Abstract][Full Text] [Related]
8. Treatable Traits in Airway Disease: From Theory to Practice. Agusti A; Gibson PG; McDonald VM J Allergy Clin Immunol Pract; 2023 Mar; 11(3):713-723. PubMed ID: 36737342 [TBL] [Abstract][Full Text] [Related]
9. Precision medicine in airway diseases: moving to clinical practice. Agustí A; Bafadhel M; Beasley R; Bel EH; Faner R; Gibson PG; Louis R; McDonald VM; Sterk PJ; Thomas M; Vogelmeier C; Pavord ID; Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29051276 [TBL] [Abstract][Full Text] [Related]
10. Moving towards a Treatable Traits model of care for the management of obstructive airways diseases. Agusti A; Barnes N; Cruz AA; Gibson PG; Heaney LG; Inoue H; Leather D; Martinez FJ; McDonald VM; Oppenheimer J; Papi A; Pavord ID; Thomas M; Walker S; Yates L Respir Med; 2021 Oct; 187():106572. PubMed ID: 34478992 [TBL] [Abstract][Full Text] [Related]
11. Asthma and COPD "overlap": a treatable trait or common several treatable-traits? Gaspar Marques J; Lobato M; Leiria Pinto P; Neuparth N; Carreiro Martins P Eur Ann Allergy Clin Immunol; 2020 Jul; 52(4):148-159. PubMed ID: 32189486 [TBL] [Abstract][Full Text] [Related]
12. The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. Polverino E; Dimakou K; Hurst J; Martinez-Garcia MA; Miravitlles M; Paggiaro P; Shteinberg M; Aliberti S; Chalmers JD Eur Respir J; 2018 Sep; 52(3):. PubMed ID: 30049739 [TBL] [Abstract][Full Text] [Related]
14. Can Treatable Traits Be the Approach to Addressing the Complexity and Heterogeneity of COPD? Cazzola M; Rogliani P; Blasi F Int J Chron Obstruct Pulmon Dis; 2023; 18():1959-1964. PubMed ID: 37705673 [TBL] [Abstract][Full Text] [Related]
15. The treatable traits approach to adults with obstructive airways disease in primary and secondary care. Thomas M; Beasley R Respirology; 2023 Dec; 28(12):1101-1116. PubMed ID: 37877554 [TBL] [Abstract][Full Text] [Related]
17. Precision medicine in chronic obstructive pulmonary disease: how far have we come? Khan MMKS; Cole AG; Mannino DM Curr Opin Pulm Med; 2022 Mar; 28(2):115-120. PubMed ID: 34652296 [TBL] [Abstract][Full Text] [Related]
18. The contribution of respiratory microbiome analysis to a treatable traits model of care. Taylor SL; O'Farrell HE; Simpson JL; Yang IA; Rogers GB Respirology; 2019 Jan; 24(1):19-28. PubMed ID: 30282116 [TBL] [Abstract][Full Text] [Related]
19. [Chronic obstructive pulmonary disease: diagnosis and treatment of stable phase of disease; personalized treatment approach using phenotype features of the disease Summary of the 2020-2021 Czech Pneumological and Phthiseological Society position paper]. Brat K; Zatloukal J; Neumannová K; Voláková E; Kudela O; Kopecký M; Plutinský M; Koblížek V Vnitr Lek; 2021; 67(4):230-239. PubMed ID: 34275309 [TBL] [Abstract][Full Text] [Related]
20. Current Approaches for Phenotyping as a Target for Precision Medicine in COPD Management. Lopez-Campos JL; Centanni S COPD; 2018 Apr; 15(2):108-117. PubMed ID: 29558165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]